Main Article Content

Authors

Samyami Sreeramula

Shiv Brat Singh

Abstract

Novel pyrazolone and oxazolone compounds are synthesised and their biological assessment is the focus of this work. The pharmacological potential of these heterocyclic compounds is highly promising, as they exhibit significant anti-inflammatory, antibacterial, and anticancer properties. To emphasise their potential as medication candidates, we talk about different synthesis processes, structure-activity connections, in vitro and in vivo assessments, and so on.

Downloads

Download data is not yet available.

Article Details

Section

Articles

References

  1. Y. Thigulla, T.U. Kumar, P. Trivedi, B. Ghosh, Chem. Sel., 2017, 7, 2721-2724.
  2. Mochida Pharmaceutical Co. Ltd. JP, 81, 127, 383 (1981).
  3. N.Henrie Robert, J Peake Clinton., G.Cullen Thomas et al.; PCT Int Appl., WO 98,20,878, Appl. 96/08,17748 (1996); Chem Abstr., 129, 16136s (1998).
  4. M. M. Ghorob and S. G. Abdel-Hamid; Indian J. Heterocycl. Chem., 4, 103-06 (1994). 320.
  5. Obatokio Fujii, Katsu Toshi, Narita Isami et al.; Jpn. Kokai Tpkkyo Koho JP, 08,269,021 (1995); Chem Abstr., 126, 74864b (1997).
  6. R. K. Russell, J. B. Press, R. A. Rampulla, J. J. Mc Nally et al.; J. Med. Chem., 31, 1786 (1988).
  7. Ranise Angelo, Bruno Olga, Schenone Silvia, Bondalalli Franceso et al.; Farmaco, 52(8-9), 547-55 (1997); Chem. Abstr., 128, 238986n (1986).
  8. Y. S. Sadanandan, N. M. Shetty and P. V. Diwan; Chem. Abstr., 117, 7885k (1990).
  9. K. Khalafallah, F. M. Abd-El Latif and M. A. Salim; Asian J. Chem., 5, 988-94 (1993).
  10. S. S. Sangopure and A. M. Mulogi; Indian J. Heterocyclic Chem., 10, 27-30 (2000).
  11. El-Sayed and A. M. Badaway; J. Heterocyclic Chem., 33, 229 (1996); 7, 273-76 (1998).
  12. H. Y. Moustafa; Indian J. Heterocyclic Chem., 7, 273-76 (1998).